Raj Reddy

Company: Canary Global

Job title: Chief Executive Officer

Bio:

Raj Reddy is a biotechnology pioneer and the President and CEO of Canary Cure, a leading gene and RNA therapy company developing innovative treatments for metabolic, obesity and rare genetic diseases. With over 10 years of experience scaling biotech ventures and specializing in the endocannabinoid system’s role in metabolic health, Raj brings deep expertise in pharmacology and medicinal chemistry to the company’s groundbreaking work. As the inventor on over 20 patents in genetics and RNA therapy, Raj leads Canary’s development of first-in-class siRNA therapeutics that transform white adipose tissue into energy-burning powerhouses. His flagship innovation, CCT-217, demonstrates unprecedented outcomes in pre-clinical models—achieving 26% weight loss while increasing lean muscle mass by 25%, a stark contrast to current therapies that cause significant muscle deterioration. Raj’s strategic vision combines cutting-edge RNA technology with AI-enhanced personalized approaches to revolutionize treatment paradigms. His previous leadership over a $500 million portfolio has honed his expertise in strategic management and market access. Driven by the transformative potential of genetic medicine, Raj is committed to unlocking new frontiers in precision medicine that enable earlier detection and more effective disease treatment through targeted genetic mechanisms.

Seminars:

Panel Discussion: Synthesizing Breakthrough Discoveries to Chart Future Directions for Accelerating Therapeutic Innovation for Broader Patient Impact 2:30 pm

Integrating cross-disciplinary insights for comprehensive understanding to identify synergistic opportunities for more effective drug development strategies Forecasting emerging trends and technologies for proactive research planning to anticipate future challenges for sustainable therapeutic pipelines Fostering global collaborations and partnerships for shared knowledge and resources to expedite clinical translation for faster patient access to novel treatmentsRead more

day: Day Two

Exploring Adipose Tissue Biology for Novel Fat-Targeting Strategies to Reduce Fat Mass More Effectively for Improved Body Composition & Health 10:00 am

Understanding adipocyte plasticity for manipulating fat cell function to promote healthier fat storage for reduced metabolic dysfunction Targeting brown and beige fat development for increased energy expenditure to boost thermogenesis for enhanced caloric burning Investigating adipose tissue remodeling for improving insulin sensitivity to reduce inflammation for better overall metabolic health Read more

day: Pre-Conference Day